Spencer James is a physician scientist at Roche with 15 years of research experience in academia and industry. His experience with machine learning started in 2009 with using random forest for predicting causes of death in survey data for population health research at University of Washington. Since then, he has worked with machine learning as well as classical statistical methods in applied research for clinical outcome prediction at Dartmouth, disease surveillance and outbreak detection with Institute of Population, Health and Development in Vietnam, population health research at Institute for Health Metrics and Evaluation, and now with the Product Development and Health Equity & Population Science divisions at Genentech, a member of the Roche Group. Spencer’s work now focuses on advancing inclusive research and representative study design in biopharmaceutical research and development through the use of population health data and clinicogenomic real-world data. Spencer has published his research in The Lancet, NEJM, JAMA, and other journals, and has presented at ASCO, ASH, DIA, WHO, and elsewhere.